You are a subscriber
If you are not already a subscriber,
Choose a subscription offer and create your account to read all content on MediapartCreate your account
Three other men are in intensive care in a Rennes hospital with what doctors fear may be irreversible brain damage after the Phase 1 clinical trial.
Reading articles is for subscribers only. Subscribe now.